SYKES Enterprises Shares Up 24.8% Since SmarTrend's Buy Recommendation (SYKE)
Comtex SmarTrend(R) - Thu Apr 17, 9:47AM CDT
SmarTrend identified an Uptrend for SYKES Enterprises (NASDAQ:SYKE) on May 7th, 2013 at $15.81. In approximately 12 months, SYKES Enterprises has returned 24.79% as of today's recent price of $19.73.
Sykes Enterprises, Incorporated to Webcast First-Quarter 2014 Financial Results
GlobeNewswire - Tue Apr 15, 11:08AM CDT
Sykes Enterprises, Incorporated ("SYKES" or the "Company"
29.4% Return Seen to Date on SmarTrend SYKES Enterprises Call (SYKE)
Comtex SmarTrend(R) - Wed Mar 19, 9:52AM CDT
SmarTrend identified an Uptrend for SYKES Enterprises (NASDAQ:SYKE) on May 7th, 2013 at $15.81. In approximately 11 months, SYKES Enterprises has returned 29.41% as of today's recent price of $20.46.
30.0% Return Seen to Date on SmarTrend SYKES Enterprises Call (SYKE)
Comtex SmarTrend(R) - Wed Mar 12, 9:20AM CDT
SmarTrend identified an Uptrend for SYKES Enterprises (NASDAQ:SYKE) on May 7th, 2013 at $15.81. In approximately 10 months, SYKES Enterprises has returned 29.98% as of today's recent price of $20.55.
Sykes Enterprises, Incorporated's Chief Financial Officer (CFO) Mike Kipphut Announces Retirement After a Decade and a Half With the Company
GlobeNewswire - Thu Feb 27, 3:00PM CST
Sykes Enterprises, Incorporated ("SYKES" or the "Company"
Sykes Enterprises, Incorporated to Present at the Baird 2014 Business Solutions Conference
GlobeNewswire - Thu Feb 20, 12:42PM CST
Sykes Enterprises, Incorporated (Nasdaq:SYKE) ("SYKES" or the "Company"
Sykes Enterprises, Incorporated Reports Fourth-Quarter and Full-Year 2013 Financial Results
GlobeNewswire - Tue Feb 18, 3:00PM CST
--Fourth Quarter 2013 Revenue Tops Business Outlook Range on Better Demand
Uptrend Call Working As SYKES Enterprises Stock Rises 30.1% (SYKE)
Comtex SmarTrend(R) - Tue Feb 18, 9:42AM CST
SmarTrend identified an Uptrend for SYKES Enterprises (NASDAQ:SYKE) on May 7th, 2013 at $15.81. In approximately 10 months, SYKES Enterprises has returned 30.11% as of today's recent price of $20.57.
Stem Cell Therapeutics Announces Appointment of Dr. Calvin R. Stiller as Chairman
Marketwire - Thu Jan 30, 6:38AM CST
Stem Cell Therapeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics, is pleased to announce that its Board of Directors has elected Dr. Calvin R. Stiller as Chairman of the Board. Dr. Stiller has been a member of the Board since July 2011 and served as Lead Director and Chair of the Governance and Nominating Committee.
Sykes Enterprises, Incorporated to Webcast Fourth-Quarter and Full-Year 2013 Financial Results
GlobeNewswire - Fri Jan 24, 9:00AM CST
Sykes Enterprises, Incorporated ("SYKES" or the "Company"